Holding(s) in Company
Updated : 17:40
Standard Form TR-1
Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i | ||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Grafton Group Public Limited Company
| ||||
2. Reason for the notification (please tick the appropriate box or boxes): [X ] An acquisition or disposal of voting rights [ ] An acquisition or disposal of financial instruments [ ] An event changing the breakdown of voting rights [ ] Other (please specify)iii:
| ||||
3. Details of person subject to the notification obligationiv : | ||||
Name: Kames Capital Plc | City and country of registered office (if applicable):
| |||
4. Full name of shareholder(s) (if different from 3.)v:
| ||||
5. Date on which the threshold was crossed or reachedvi:14/03/2019
| ||||
6. Date on which issuer notified: 19/03/2019
| ||||
7. Threshold(s) that is/are crossed or reached: 3%
| ||||
8. Total positions of person(s) subject to the notification obligation: | ||||
% of voting rights attached to shares (total of 9.A) | % of voting rights through financial instruments | Total of both in % (9.A + 9.B) | Total number of voting rights of issuervii | |
Resulting situation on the date on which threshold was crossed or reached | 3.03% | 0.00% | 3.03% | 237,765,520 |
Position of previous notification (if applicable) | 2.96% | 0.00% | 2.96% | |
9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii: | |||||||||
A: Voting rights attached to shares | |||||||||
Class/type of ISIN code (if possible) | Number of voting rightsix | % of voting rights | |||||||
Direct
|
Indirect
|
Direct
|
Indirect
| ||||||
IE00B00MZ448 | 5,086,199 | 2,122,892 | 2.14% | 0.89% | |||||
SUBTOTAL A | 7,209,091 | 3.03% | |||||||
B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations | |||||||||
Type of financial instrument | Expiration | Exercise/ | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights | |||||
SUBTOTAL B.1 | |||||||||
B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations | |||||||||
Type of financial instrument | Expiration | Exercise/ | Physical or cash settlementxii | Number of voting rights | % of voting rights | ||||
SUBTOTAL B.2 | |||||||||
10. Information in relation to the person subject to the notification obligation (please tick the applicable box):
[X] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii
[ ] Full chain of controlled undertakings through which the voting rights and/or the
| |||
Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Kames Capital:- Kames Capital Plc
Kames Capital ICVC Kames Capital VCIC
| |||
11. In case of proxy voting: Kames Capital Plc will cease to hold [% and number] voting rights as of [date]
| |||
12. Additional informationxvi: Kames Capital plc acquires holdings as agent and discretionary manager for underlying clients including: UCITS funds, other collective investment schemes and segregated, institutional clients. Exercise of voting rights is controlled by Kames Capital plc. | |||
Done at Kames Capital Plc Edinburgh, Scotland, United Kingdom on 15/03/2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.